Full-Time

Research Associate

Plant Transformation

Inari Agriculture

Inari Agriculture

501-1,000 employees

CRISPR-driven seed enhancement for higher yields

Compensation Overview

$59.4k - $81.7k/yr

+ Short-term Incentive + Long-term Equity

Cambridge, MA, USA

In Person

Category
Biology & Biotech (2)
,
Requirements
  • A Bachelor’s degree or equivalent with 3+ years of work experience, or a Master’s degree in agriculture or plant biology or a related field
  • Demonstrated knowledge and experience in plant transformation and tissue culture, including Agrobacterium culture preparation
  • Experience with aseptic technique and media preparation
  • Ability to learn new technologies and techniques, develop and improve protocols, and effectively communicate findings
  • Adaptability and enthusiasm for new challenges, innate curiosity, and a passion for developing high impact solutions
  • Ability to work both independently and collaboratively in a fast-paced environment
  • Demonstrated organization, time management, and multitasking skills
  • Demonstrated knowledge and wet-lab experience in molecular and/or biology techniques such as DNA/RNA extraction, PCR/qPCR, or next generation sequencing workflows such as library preparation
  • Experience and familiarity with using Laboratory Information Management Systems or Electronic Lab Notebooks, such as Benchling
Responsibilities
  • Perform experiments independently and with cross-functional teams, related to plant transformation and tissue culture using established protocols in multiple crops of interest
  • Optimize established plant transformation/transient plant assays as well as explore developing and onboarding new assays
  • Conduct experiments to explore novel methods to achieve gene editing in plants and/or transformation
  • Collaborate with Scientists and other Research Associates to identify and test new technologies to support company projects and increase quality and throughput
  • Drive ideation and troubleshooting of experimental protocols, implement solutions, and clearly communicate results and next-step recommendations to project teams and stakeholders
  • Maintain accurate and detailed records of experiments and effectively communicate scientific results and progress
  • Work in a fast-paced environment and deliver results on both high-risk experiments and established assays
  • Develop, author, and execute SOPs for new assay methods and ensure proper training of end users
Desired Qualifications
  • Experience with laboratory automation, especially next generation sequencing automation such as MiSeq or Nanopore technology
  • Experience with gene editing and CRISPR-Cas technologies
  • Experience with tissue culture techniques in commercially important crops such as soybean, corn and wheat

Inari Agriculture uses advanced genetics to improve crop performance. It builds detailed knowledge about how plant genes affect field results, then creates diversity by making precise, targeted changes to a plant’s DNA with CRISPR. After testing the edits, Inari puts the improvements into elite parent seeds and partners with seed companies to scale up and distribute those seeds to farmers. Revenue comes from selling these enhanced seeds through its partner network. The company differentiates itself by combining plant genetics research with targeted gene-editing and a partner-based distribution model that reaches a wide market. Its goal is to help farmers achieve higher yields and better resilience to environmental stresses by delivering better seeds across the agricultural supply chain.

Company Size

501-1,000

Company Stage

Late Stage VC

Total Funding

$751.3M

Headquarters

Cambridge, Massachusetts

Founded

2016

Simplify Jobs

Simplify's Take

What believers are saying

  • Lisa Nunez Safarian appointed CEO in 2025, leveraging Bayer seed expertise.
  • $144M Series G funding in January 2025 boosts valuation to $2.17B.
  • Ghent facility opened May 2025 triples plant growth capacity for R&D.

What critics are saying

  • Bayer replicates multiplex editing using Safarian's knowledge within 12 months.
  • Corteva's 2024 CRISPR corn captures U.S. market before Inari commercializes.
  • EU GMO rules block Ghent expansion, halting 30% R&D growth immediately.

What makes Inari Agriculture unique

  • SEEDesign platform integrates AI predictive design and multiplex gene editing for seeds.
  • Asset-light model licenses enhanced seeds to independent seed companies.
  • Targets soybeans, corn, and wheat with 10-20% yield increases and 40% input reductions.

Help us improve and share your feedback! Did you find this helpful?

Your Connections

People at Inari Agriculture who can refer or advise you

Benefits

Health insurance package

Flexible PTO

401k plan

Performance Bonus

Commuter Checks & Assistance

Company Social Events

Free Lunch or Snacks

Growth & Insights and Company News

Headcount

6 month growth

3%

1 year growth

4%

2 year growth

3%
Inari
Mar 25th, 2026
Inari named one of TIME's America's Top GreenTech Companies 2026.

Inari named one of TIME's America's Top GreenTech Companies 2026. Inari was recognized today on TIME's list of America's Top GreenTech Companies 2026. Presented by TIME and Statista, the leading statistics portal and industry ranking provider, the list recognizes 250 companies based on three evaluation criteria: * Positive Environmental Impact: To assess a company's positive environmental impact, Statista partnered with The Upright Project to quantify the holistic impact of a company's product and service portfolio, including its alignment with the UN Sustainable Development Goals (SDGs). * Financial Strength: For the evaluation of financial strength, Statista analyzed revenue, employee and funding data, obtained from publicly available sources like annual reports, company websites, through media monitoring, and via databases. * Innovation Drive: For the innovation drive, Statista cooperated with LexisNexis(R) Intellectual Property Solutions to analyze the quantity and impact of a company's IP intellectual property) portfolio. Statista publishes hundreds of worldwide industry rankings and company listings with high-profile media partners. This research and analysis service is based on the success of statista.com, the leading data and business intelligence portal that provides statistics, relevant business data, and various market and consumer studies and surveys.

The Healthcare Technology Report
Nov 26th, 2025
Inari Names Lisa Nunez Safarian as Chief Executive Officer

Inari names Lisa Nunez Safarian as Chief Executive Officer. Inari, a company focused on designing seeds to improve crop performance, has announced that Lisa Nunez Safarian has been appointed as its new Chief Executive Officer. Safarian has served on Inari's Board since May 2025 and will continue in the role while also joining Flagship Pioneering as a CEO-Partner. She previously held senior leadership positions at Monsanto and later Bayer, where she helped expand seeds, traits, licensing, and crop protection businesses valued at approximately $12 billion. Become a subscriber. Please purchase a subscription to continue reading this article. Ignacio Martinez, Co-Founder and Board Chair, noted, "Lisa is a visionary leader who will propel Inari into its next phase of growth. Her deep expertise is matched only by her steadfast commitment to helping farmers achieve better outcomes. I look forward to continuing to work closely with her at Inari and leveraging her expertise for the benefit of the broader Flagship Pioneering ecosystem." Safarian expressed confidence in the company's direction and product maturity, saying, "When I joined the board, I was immediately impressed by Inari's level of sophistication and how far they had advanced their product pipeline." Inari's work centers on its AI-enabled SEEDesign platform, which integrates genomic analysis and multiplex gene editing to develop high-yield seed designs for soybeans, corn, and wheat. Safarian added that the demonstrated results represent "a once-in-a-lifetime opportunity" as the company aims to advance crop productivity and support long-term food system sustainability.

World Bio Market Insights
May 22nd, 2025
Inari's new facility in Ghent triples local plant growth capacity

Inari's new facility in Ghent triples local plant growth capacity.

PR Newswire
May 14th, 2025
Inari Grows Greenhouse Operations In Ghent, Belgium

GHENT, Belgium, May 15, 2025 /PRNewswire/ -- Inari, the SEEDesign™ company, today marked the grand opening of a state-of-the-art controlled environment facility in Ghent, Belgium. With more than 2,000 square meters of new greenhouse space, the site triples the company's indoor plant growth capacity in the region – further accelerating research and development of step-change seed products

AgTech Media Group
Apr 4th, 2025
Inari Appoints Vivien Bonazzi as CDO to Strengthen Predictive Design Capabilities

Inari (Profile) has appointed Dr. Vivien Bonazzi as Chief Data Officer, effective April 1.